在移植人群中治疗腺病毒感染:除了cidofovir之外的治疗选择?

Niyati Narsana1, David Ha2,3, Dora Y Ho3

  • 1Division of Infectious Diseases, UC Davis Medical Center, Sacramento, CA 95817, USA.

Viruses
|May 28, 2025
PubMed
概括

腺病毒感染对移植患者构成严重风险. 本综述检查了当前和新的治疗方法,强调了需要更好的疗法和标准化的协议管理腺病毒 (AdV) 在免疫功能低下的个体.

相关概念视频

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
229